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Abstract
Though Ghana has high hypertension prevalence, the country lacks current national salt consumption data required
to build and enhance advocacy for salt reduction. We explored the characteristics of a randomly selected sub
sample that had valid urine collection, along with matched survey, anthropometric and BP data (n = 839, mean
age = 60y), from the World Health Organization’s Study on global AGEing and adult health (WHO-SAGE), Ghana
Wave 3, n = 3053). We also investigated the relationship between salt intake and blood pressure (BP) among the
cohort. BP was measured in triplicate and 24 h urine was collected for the determination of urinary sodium (Na),
potassium (K), creatinine (Cr) and iodine levels. Hypertension prevalence was 44.3%. Median salt intake was 8.3 g/
day, higher in women compared to men (8.6, interquartile range (IQR) 7.5 g/day vs 7.5, IQR 7.4 g/day, p < 0.01),
younger participants (18–49 y) compared to older ones (50+ y) (9.7, IQR 7.9 g/day vs 8.1, IQR 7.1 g/day, p < 0.01)
and those with higher Body Mass Index (BMI) (> 30 kg/m2) compared to a healthy BMI (18.5–24.9 kg/m2) (10.04, IQR
5.1 g/day vs 6.2, IQR 5.6 g/day, p < 0.01). More than three quarters (77%, n = 647) of participants had salt intakes
above the WHO maximum recommendation of 5 g/d, and nearly two thirds (65%, n = 548) had daily K intakes
below the recommended level of 90 mmol. Dietary sodium to potassium (Na: K) ratios above 2 mmol/mmol were
positively associated with increasing BP with age. Population-based interventions to reduce salt intake and increase
K consumption are needed.
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Introduction
Cardiovascular diseases (CVDs) remain a major con-
tributory factor for mortality and morbidity worldwide,
accounting for 17.9 million deaths in 2016, and repre-
senting a third of all deaths globally [1]. While Low-
and Middle-Income Countries (LMICs) already share
the greatest impact of CVD-related deaths, with rates
of 300–600 deaths per 100,000 population, these are
predicted to increase, causing premature, avoidable loss
of lives [2]. Hypertension is a major risk factor for CVD
and accounted for more than 50% of CVD-specific
deaths in 2012 [3]. It has been estimated that the bur-
den of hypertension will increase to approximately 1.56
billion people globally by 2025, with larger populations
of hypertensives living in LMICs [3–5].
Hypertension is a common condition in Ghana, where
its prevalence has increased more than two-fold over
just two decades (1988–2007) [6]. A recent nationally
representative study among participants largely 50 years
and older, in Ghana, reported the prevalence of hyperten-
sion to be 58.9% in adults with about one-fifth of those
with hypertension being aware of having the condition [7]].
Reducing population-level prevalence of hypertension by
30% by the year 2030 is identified by WHO as one of the
nine voluntary global targets to reduce non communicable
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diseases (NCDs) [8]. Salt reduction has been identified by
the WHO as one ‘best buys’ approach to reduce overall
CVD risk through lowering of (BP) [9].
Increased consumption of salt (> 2 g Na/day, equiva-
lent to 5 g salt/day) together with insufficient potassium
(K) intake (< 3.5 g/day) are strongly associated with a
number of NCDs including hypertension [10–14]. Sev-
eral systematic literature reviews, meta analyses and
randomized-controlled trials have shown that reduced
sodium (Na) consumption results in a decline in blood
pressure in both hypertensives and normotensive adults
[12, 14–17], which saves lives [18]. In view of this,
‘WHO’s SHAKE the Salt Habit’ resource has emphasized
the importance of measuring and monitoring population
salt consumption patterns in order to inform stakeholders
about strategies to reduce salt intake and evaluate the
effect of any implemented salt reduction programmes
[19]. Though Ghana is committed to the World Health
Assembly’s target of 30% relative reduction in the popula-
tion salt intake by 2025 [10], the country has made slow
progress towards achieving the target due to other com-
peting public health priorities and limited resources [20].
Few studies have been conducted to assess salt intake
in the Ghanaian population [21]. A lack of recent,
nationally representative data on population salt con-
sumption among adults has further been a disincentive for
advocacy around salt reduction efforts [22]. The current
study was undertaken to obtain a reliable estimate of
population salt intake and salt use behaviour, and to assess
the relationship between salt and K intake with blood
pressure (BP) in Ghanaian adults.
Methods
Study design, population and outcomes
This study is a nested sub study of WHO’s Study on
global AGEing and adult health (WHO - SAGE) Wave 3
Ghana, which collected 24 h urine samples for analysis
of Na and K [23]. WHO - SAGE is a longitudinal cohort
study conducted in six LMICs (China, Ghana, India,
Russia, Mexico and South Africa) with the aim to exam-
ine the ageing process and address health inequalities
among adult populations [24]. Participants were sampled
based on a design used in the 2003 World Health Survey
with primary sampling units (households) stratified by
region and location (urban/rural) The study design ran-
domly selects 24 households from an enumeration area
(twenty 50+ year households and four 18-49 year house-
holds). In the 50+ year households, all participants are
selected and compares with a smaller number of partici-
pants selected from the 18-49 year households, details of
which are described elsewhere [25]. WHO SAGE Ghana
Wave 3 data collection was completed over a period of 1
year (July 2018–June 2019) with n = 1100 24 h urine
samples collected nationwide. Out of 5570 participants
recruited for WHO - SAGE Ghana Wave 3, 1102 (20%),
were randomly selected to provide urine samples (nested
sub study). Of these, 76.7% (n = 844) had successful (BP)
data and 88.6% (n = 976) had complete urine samples.
However, fewer participants (n = 839) had a complete
urine collection, accompanied with survey, anthropo-
metric and valid BP data (Fig. 1).
Field worker teams consisted of 3–5 interviewers per
team who visited participants in their homes and work-
places to conduct interviews. All field workers were
trained by the central WHO SAGE team with standard-
ized survey materials [24]. Surveys were conducted in
the participants’ preferred home language with the use
of the computer assisted personal interview (CAPI)
method.
The WHO/Pan American Health Organization
(PAHO) protocol was utilised in the determination and
collection of Na, K and Cr in the 24 h urine collections.
In collecting urine samples, 5-l urine bottles containing
1 g thymol as preservative, were given to participants to
collect 24 h urine. The collection procedure was thor-
oughly explained to participants. In brief it is as follows:
1) void the ‘first urine’ and note the time but include the
‘last urine’ 2) keep the bottles to yourself and collect
only your own urine 3) collect all urine passed within
the 24 h and 4) keep collected urine in a cool place [26].
The 24 h urine was collected, thoroughly mixed, volumes
recorded, 3 aliquots of 5 ml were generated and samples
kept in cold boxes and transported to the Noguchi
Memorial Institute for Medical Research of the University
of the Ghana (NMIMR-UG). Urine samples were
considered valid if the volume was ≥300ml [27, 28]. Add-
itionally, iodine was assessed for analysis because Ghana
had a universal iodine programme in place.
Analysis were undertaken by NMIMR-UG, that
followed the WHO/PAHO protocol for quantitative ana-
lysis of Na, K, Cr in urine samples [26]. Urine samples for
iodine analyses were stored at − 20° and batch analysed
using the Sandell-Kolthoff method with ammonium per-
sulfate digestion and microplate [29]. Creatinine excretion
in this population was much lower than that reported for
many other populations, from which Cr cut-off values
have been determined to indicate completeness of 24 h
urine collection [28]. Because of this, only urine volume
was used to indicate whether urine samples were consid-
ered to represent completeness. This approach has been
used in other multi-country studies including; the Inter-
national Population Study on Macronutrients and Blood
Pressure [INTERMAP] and the International Study of
Sodium, Potassium, and Blood Pressure [INTERSALT]
[27]. In the first enumerator areas (EAs) sampled within
the Accra region, some calculated salt values were
unfeasibly high (> 40 g/d, n = 40,) due to unacceptable
storage conditions [30]. A follow-up validation study
Menyanu et al. BMC Nutrition            (2020) 6:54 Page 2 of 15
conducted in n = 67 participants included the collec-
tion of repeated 24 h urine samples from the same
participants in one EA (Alajo; n = 19), while an add-
itional two non-urine EAs from the larger survey
sample were visited as a comparator (Mataheko; n =
24 and Nima; n = 24). A second laboratory (Liberty
Medical Laboratory, Accra) also performed duplicate
analyses in the validation study. Values for Dosise EA
(n = 23) were excluded after the validation study be-
cause they were confirmed as being unfeasible, and
the validation study values replaced original measures
for the case of Alajo (n = 16; 3 barcodes of urine
samples in validation study were excluded because
they could not be matched with those of the original
study) (Supplementary Table 1).
Sodium (mmol/l) in the 24 h urine sample was con-
verted to salt (g/d) using the formula: Na mmol/l × 24 h
volume (litres) × 23.1 (molecular weight of Na)/390 (390
mg Na per 1 g Nacl (salt). From this variable, partici-
pants were categorised as having low (< 5 g/day),
medium (5–9 g/day) or high (> 9 g/day) salt intake. K
(mmol/l) in the 24 h urine sample was converted to K
(mmol/d) using the formula: K (mmol/l) × 24 h volume
(litres) [31]. The ratio Na (mmol/L) to K (mmol/L) was
created (Na:K) and categorised as low (< 2), medium (2–5)
or high (> 5). BP was measured by field workers with wrist
worn BP devices with positional sensors (Omron R6,
Japan) [32] that have been validated by the European
Society of Hypertension International Protocol [32–34].
After being seated with legs uncrossed for 5 min, three BP
Fig. 1 Study flow chart
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readings were taken on the left wrist (1min between each
measurement) while the wrist was placed precisely at the
level of heart. The last two readings were averaged as a
measure of the participant’s BP. Hypertension classifica-
tion was based on the European Society for Hypertension
Guidelines (2018) which defines hypertension as systolic
≥140 and/or diastolic ≥90mmHg [35]. BP readings in the
database were determined valid if: Systolic (SBP) > Dia-
stolic (DBP); and SBP was between 80 and 270mmHg;
and DBP was between 40 and 180mmHg; and SBP minus
DBP (Pulse Pressure, PP) > 13mmHg. Mean Arterial Pres-
sure (MAP) is the average arterial pressure throughout
one cardiac cycle, systole, and diastole. MAP was calcu-
lated using the formulae: MAP = SBP + 2 (DBP)/3 [36].
Hypertension status was measured as self-reported treat-
ment or having a measured BP ≥ 140/90mmHg. Hyper-
tension awareness was based on self-reported previous
diagnosis of hypertension in those with BP ≥ 140/90
mmHg. Treatment was determined from self-reported
medication use for hypertension within the last 2 weeks.
Hypertension control was determined by self-reported
medication use within the last 2 weeks and a measured BP
less than 140/90mmHg. Individuals with no current
medication use and a measured BP < 140/90mmHg were
categorized as non-hypertensive.
Weight was measured with calibrated scales, while
height was measured with a portable stadiometer. Data
were also collected on health indicators such as tobacco,
alcohol use, salt use behaviours and previous disease
conditions. Physical activity levels were measured using
the Global Physical Activity Questionnaire [37]. For salt
use behaviour questions, responses such as ‘always’ and
‘often’ were combined to represent ‘frequent use’, whilst
‘sometimes’ and ‘rarely’ were combined to represent ‘in-
frequent use’.
Prior to taking part in the study, study measures were
explained to participants in their home languages and
written informed consent was obtained. The study
complied with the Declaration of Helsinki with ethical
approval from the WHO Ethics Committee (RPC 149)
and the University of Ghana Medical School Ethics and
Protocol Review Committee (MS-Et/M.03 - P 3.1/2005–
2006).
Statistical analysis
Data were analysed using Stata Statistical Software: Release
15 (Stata Corp LLC, 2017; College Station, USA). Data dis-
tribution was checked visually and with the Shapiro Wilks
test for normality. Descriptive statistics of frequencies,
percentages and median (interquartile range, IQR) were
used to describe participants’ characteristics. Categorical
variables were evaluated using frequencies, Pearson’s Chi-
Square and Fisher’s Exact tests. Comparison between
groups for non-parametric data was examined using
Mann-Whitney U and Kruskal-Wallis tests and Spearman’s
Rho was used to test for correlations. Linear regressions
were used to evaluate the associations between variables.
To test regression slopes for equality between the three salt
level groups and between the three Na:K ratio groups, the
interaction terms of groups with age was added into the
models. To test if a difference in the group’s coefficients
(i.e. slope) was present, the F test was applied. If significant,
post-estimation was pursued to identify which group dif-
fered from the others.
Results
Table 1 compares sociodemographic characteristics of
the nested sub study sample with those included in the
total Wave 3 survey collection.
Hypertension prevalence in the nested sub study was
44.3% (n = 370) with 41.4 and 46.1% for men and
women respectively. Of those with hypertension, 59.7%
were aware of their condition (n = 222) of which 69.1%
(n = 154) were receiving prescribed antihypertensive
medication. Of those being treated for hypertension,
51% (n = 77) had controlled BP (ie BP ≤ 140/90).
Among participants with both urine, survey data and
BP data (n = 839), median intake of salt was equivalent
to 8.3 g/day (IQR 7.5) (mean = 10.2 g ± 7.2). Salt intake
was higher in: (1) women compared to men; median 8.6
(7.5)g/day vs 7.5 (7.4)g/day, p < 0.01; (2) younger partic-
ipants (18–49 y) compared to older ones (50+ y); median
9.7 (7.9)g/day vs 8.1 (7.1)g/day, p < 0.01; and (3) those
with higher BMI (> 30 kg/m2) compared to a desirable
BMI (18.5–24.9 kg/m2); median 10.04 (5.1)g/day vs 6.2
(5.6)g/day, p < 0.01. There was no significant difference
in salt consumption between rural and urban dwellers.
Overall, 77.7% (n = 647) of participants had salt intakes
above the WHO maximum recommendation of 5 g/d,
with 38.9% consuming more than twice this level (> 10 g/
d, n = 321) and 16.3% consuming more than three times
the recommended level (> 15 g/d, n = 137). More men
than women (27.1% (n = 73) vs 19.9% (n = 122); p = 0.02)
and older participants than younger ones (24.8% (n = 164)
vs 12.1% (n = 21); p < 0.01) achieved the WHO’ salt rec-
ommendation of ≤5 g salt/day (Supplementary Tables 2
and 3).
According to groupings by salt intake (low, < 5 g/d;
medium, 5-9 g/d; high, > 9 g/d), those with higher salt
intakes were significantly younger, had higher BMI, a
higher urinary K excretion, a higher urinary Na: K and
lower urinary iodine concentrations. However, BP and
hypertension status did not differ between the groups
(Table 2).
In response to the salt behaviour questions (Supplementary
Table 4), 12.8% (n = 107) of participants reported that they
frequently (always and often) added salt to food at the table
with significantly greater numbers of younger (27.3%, n = 28,
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Table 1 Demographic profile of SAGE GHA W3 survey participants and subsample with valid urine data (urine data considered valid
if volume≥ 300 ml)
Main SAGE cohort (n = 3053) Salt sub study sample (n = 839) P-value
Age
Years 60 (20) 60 (19) 0.3294
18–49 years, n (%) 717 (23.5) 174 (20.7) 0.0100
50 plus years, n (%) 2336 (76.5) 665 (79.3) 0.4494
Sex, n (%) 0.001
Men 1183 (38.8) 371 (32.3)
Women 1870 (61.2) 568 (67.7)
Ethnicity, n (%) < 0.0001
Akan 1544 (50.6) 497 (59.2)
Ewe 216 (7.1) 58 (6.9)
Ga-Adangbe 224 (7.3) 45 (5.4)
Gruma 30 (1.0) 6 (0.7)
Grusi 76 (2.5) 12 (1.4)
Guan 38 (1.2) 16 (1.9)
Mande-Busanga 63 (2.1) 3 (0.4)
Mole-Dagbon 174 (5.7) 24 (2.9)
Other 612 (20.0) 174 (20.7)
Residence, n (%) < 0.0001
Urban 1301 (42.6) 457 (54.5)
Rural 1752 (57.4) 382 (45.5)
Marital status, n (%) 0.002
Never married 208 (6.8) 39 (4.6)
Married/cohabiting 1760 (57.7) 470 (56.0)
Separate/divorced 369 (12.1) 87 (10.4)
Widowed 715 (23.4) 243 (29.0)
Never been to school, n (%) 1119 (36.7) 240 (28.6) < 0.0001
Education (years) 10 (5) 10 (5) 0.0139
BMI kg/m2 24.2 (6.8) 25.4 (7.4) < 0.01
Waist to height ratio 0.54 (0.11) 0.56 (0.13) < 0.01
Never used alcohol, n (%) 1865 (61.3) 483 (57.6) 0.052
Never used tobacco, n (%) 2739 (90.0) 759 (90.5) 0.68
Systolic BP (mm Hg) 124 (26.5) 126.5 (29) < 0.01
Diastolic BP (mm Hg) 76 (17) 76.5 (17) 0.83
Mean Arterial Pressure (Map) mmHG 92.5 (19.2) 93.2 (20.7) 0.24
Hypertension, n(%) 1132 (37.6) 370 (44.3) < 0.01
Diabetes, n(%) 157 (5.2) 67 (8.0) 0.01
Portions of fruit, n(%) 0.05
Met WHO’s recommendation of at least 5 servings
of friuts and vegetables
1591 (57.4) 442 (54.5) 0.14
Frequently add salt to food at table, n(%) 642 (21.1) 107 (12.7) < 0.01
Frequently add salt to food during cooking, n(%) 2527 (83.0) 672 (80.1) 0.05
Believe they consume too much salt, n(%) 265 (8.8) 92 (11.0) 0.05
Believe a high salt diet is bad for health, n(%) 2247 (75.9) 651 (80.0) 0.02
Regularly control of salt intake, n(%) 1243 (42.1) 394 (48.5) < 0.01
Nested sub sample: all respondent with CAPI data and valid urine, sex and age recorded. Some variables may contain missing data. Data are presented as
median (IRQ) unless otherwise indicated. Hypertensive by measured BP ≥ 140 and/or 90 mmHg or previous diagnosis (self-reported). Ethnicity, marital status,
education, alcohol/tobacco use and diabetes prevalence by self-report. Mann-Whitney Test used to compare medians, Pearson Chi-Square test and Fisher’s
Exact Test used to compare proportional data
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Table 2 Nested cohort by salt excretion levels, low, medium and high salt groups, WHO – SAGE Ghana Wave 3 (2019)
Characteristics Low salt
< 5 g/d
(n = 186)
Medium salt
5-9 g/d
(n = 269)
High salt
> 9 g/d
(n = 378)
p value
Age yrs 64 (20) 60 (17) 58 (18) < 0.01
Sex male, n (%) n = 185
73 (39.5)
n = 269
90 (33.5)
n = 378
105 (27.8)
0.02
Ethnicity n (%) n = 184 n = 268 n = 376 0.03
Akan 122 (66.3) 168 (62.7) 203 (54.0)
Ga 7 (3.8) 11 (4.1) 27 (7.2)
Ewe 14 (7.6) 18 (6.7) 24 (6.4)
Mole-dagbon 5 (2.7) 6 (2.2) 13 (3.5)
Mole-busanga 1 (0.5) 0 (0.0) 2 (0.5)
Grusi 3 (1.6) 3 (1.1) 6 (1.6)
Guan 0 (0.0%) 11 (4.1%) 5 (1.3)
Gruma 1 (0.5) 3 (1.1) 2 (0.5)
Other 31 (16.8) 48 (17.9) 94 (25.0)
Urban n (%) n = 185
102 (55.1)
n = 269
149 (55.4)
n = 378
200 (52.9)
0.79
Education (years) n = 118
10 (5)
n = 179
10 (3)
n = 250
10 (5)
0.07
BMI, kg/m2 n = 179
23.8 (6.5)a
n = 258
25.5 (7.8)
n = 356
26.2 (7.5)a
< 0.01
Salt intake g/d n = 186
3.6 (1.5)ab
n = 269
6.7 (2.0)ac
n = 371
13.4 (8.9)bc
< 0.01
K intake, mmol/d n = 186
32.0 (25.8)ab
n = 269
54.9 (43.8)ac
n = 378
112.3 (115.8)bc
< 0.01
Na: K n = 186
1.7 (1.2)ab
n = 269
2.0 (1.4)ac
n = 378
2.3 (1.9)bc
< 0.01
Urinary iodine excretion, mmol/day n = 150
166.2 (168.5)b
n = 211
148.2 (131.4)a
n = 292
117.6 (132.8)ab
< 0.01
Systolic BP, mmHg n = 186
129 (31.0)
n = 266
126 (31.0)
n = 375
126.5 (29.0)
0.73
Diastolic BP, mmHg n = 188
76 (18.0)
n = 270
75.5 (17)
n = 379
77.5 (117.0)
0.68
Pulse pressure, mmHg n = 186
50.5 (16.7)
n = 266
49.5 (17.6)
n = 375
49.5 (16)
0.20
Mean Arterial Pressure (MAP), mmHg n = 185
94.2 (21.3)
n = 266
110 (41.0)
n = 376
93.5 (19.4)
0.85
Hypertension Prevalence, n (%) n = 186
94 (50.5)
n = 268
110 (41.0)
n = 378
166 (44.3)
0.13
Hypertension awareness, n (% of hypertension prevalence) n = 94
51 (54.8)
n = 110
62 (55.4)
n = 166
108 (65.1)
0.16
Hypertension medication, current use n
(% of hypertension awareness)
n = 51
31 (60.8)
n = 62
47 (75.8)
n = 108
74 (68.5)
0.23
Hypertension control, n (% of Hypertension medication) n = 31
16 (51.6)
n = 47
22 (46.8)
n = 74
39 (52.7)
0.82
Stroke, n (%) n = 185
6 (3.2)
n = 269
6 (2.2)
n = 378
6 (1.6)
0.44
Diabetes, n (%) n = 185
10 (5.4)
n = 269
24 (8.9)
n = 378
32 (8.5)
0.37
Tobacco use, n (%) n = 182
25 (13.7)
n = 269
25 (9.3)
n = 378
29 (7.7)
0.72
Alcohol use, n (%) n = 182 n = 269 n = 378 0.82
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p = 0.02) and rural (61%, n = 61, < 0.01) dwellers responding
affirmatively to this question. More than three quarters
(80.1%, n = 671) of the surveyed population reported that
they frequently added salt to food at home during cooking
while 60.9% (n = 508) perceived themselves to consume the
right amount of salt. While 19.9% (n = 126) did not know
that a high salt diet could cause a serious health problem,
48.5%, (n = 394) of the participants reported actively doing
something on a regular basis to control their salt intake. Of
those who knew a high salt diet could cause a serious health
problem, 58.9% (n = 378) did something on a regular basis to
control their salt intake.
Almost two-thirds (65%, n = 548) of participants did
not meet the daily K recommendation of ≥90mmol [38],
with those in the lowest salt intake group having the
lowest urinary concentrations. While 42.6% (n = 141) of
urban participants met the guidelines for K intake, this
was the case for only 28.6% (n = 101) of participants
residing in rural areas (p < 0.01). Only 7.6% (n = 63)
achieved the recommended Na: K ratio of ≤1 mmol [38].
There was a strong positive correlation between 24 h
urinary Na and K concentrations (Spearman’s rho = 0.71,
p < 0.01). Linear regression indicated that urinary Na
excretion accounted for more than half the variability in
urinary K excretion (R2 = 0.51, F (1, 832) = 861, p = <
0.01). Urinary K excretion increased by 0.71 mmol/day
for each mmol/day increase in urinary Na such that Na:
K ratio was significantly higher in the high salt group
compared to the low salt group (median 2.3 (1.9)g/day
vs 1.7 (1.9)g/day, respectively, p < 0.01).
The high Na: K group had a significantly higher BMI
than those in the lowest Na: K group (median 28.1, IQR
8.2 vs 24.8, IQR 7.0, p = 0.01) and had higher number of
participants who reported doing something on regular
basis to control their salt intake than those in the lowest
Na: K group (61.5%, n = 15 vs 42.7%, n = 166, p < 0.01)
(Table 3).
Excluding all participants on treatment for hyperten-
sion (n = 154), a Spearman’s rank order correlation
showed no association between Na excretion, K excre-
tion or Na: K ratio and SBP, DBP or PP. We also found
no significant difference between the regression slopes
of SBP, DBP or PP with age in low (< 5 g/d, n = 154),
medium (5-9 g/d, n = 220) and high (> 9 g/d, n = 302)
salt groups (Fig. 2). However, there was an association
between BP and the age regression slope according to
urinary Na: K ratio. Compared with low Na: K ratio (< 2)
and medium Na: K (2–5) ratios, the high Na: K group
(> 5) had a significantly steeper slope with age for both
SBP and DBP (p = 0.01 and p < 0.01 respectively). No
significant differences for the slopes in all three Na: K
groups was found for PP (Fig. 3). Among the high salt
group (> 9 g/d), univariate analysis showed a significant
relationship between age, father’s education, diabetes, K
and physical activity with SBP while sex, age and father’s
education were associated with DBP.
Discussion
In a nationally representative sample of adult Ghanaians
(50 years and older), we report that 24 h urinary Na
excretion equated to a median salt intake of 8.3 g/day,
with more than three-quarters of participants having salt
intakes in excess of the WHO recommendation of < 5 g/
day. This is considerably higher than median salt consump-
tion values of 6.8 g and 7.2 g/day reported by recent studies
from South Africa [31, 39], a country that has adopted
Table 2 Nested cohort by salt excretion levels, low, medium and high salt groups, WHO – SAGE Ghana Wave 3 (2019) (Continued)
Characteristics Low salt
< 5 g/d
(n = 186)
Medium salt
5-9 g/d
(n = 269)
High salt
> 9 g/d
(n = 378)
p value
80 (44.0) 115 (42.8) 156 (41.3)
Fruits and Veg., met recommendation n (%) n = 186
97 (52.2)
n = 269
152 (56.5)
n = 378
193 (51.1)
0.38
Frequently adds salt to food at the table, n (%) n = 158
24 (13)
n = 269
35 (13)
n = 279
(12.4)
0.65
Frequently adds salt to cooking at home, n (%) n = 185
149 (80.5)
n = 296
225 (83.6)
n = 378
291 (77)
0.05
Believe that they are eating just the right amount of salt n (%) n = 185
105 (56.8)
n = 267
169 (63.3)
n = 376
228 (60.6)
0.18
Believe a high salt diet can cause a serious health problem, n (%) n = 180
144 (80.0)
n = 259
207 (79.9)
n = 368
296 (80.4)
0.99
Does something to control salt consumption, n (%) n = 183
82 (44.8)
n = 260
126 (48.5)
n = 363
182 (50.1)
0.50
Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body; hypertension prevalence, BP ≥ 140/90 or previous diagnosis; Current
use of hypertension medication represents current use in the last 2 weeks; BMI, body mass index; tobacco use by self-report; alcohol use by self-report; met fruits
and vegetable recommendation indicates consumed five or more servings of fruits and vegetables a day; salt behaviour responses, frequently indicates ‘always’
and ‘often’; continuous variables compared using Independent Kruskal-Wallis Test and categorical variables compared using Pearson Chi-Square Test and Fisher’s
Exact Test. a, b, c; sig at p < 0.05
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Table 3 Nested cohort by urinary sodium to potassium (Na:K) ratio, low, medium and high groups, WHO – SAGE Ghana Wave 3 (2019)
Characteristics Low Na: K (< 2)
n = 399
Medium
Na: K (2–5)
n = 389
High Na: K (> 5)
n = 41
p value
Age yrs 60 (18) 61 (19) 58 (22) 0.44
Sex male, n (%) n = 399
139 (34.8)
n = 389
116 (29.8)
n = 41
12 (29.3)
0.29
Ethnicity n (%) n = 397 n = 387 n = 41 < 0.01
Akan 229 (57.7) 246 (63.6) 17 (41.5)
Ga 5 (1.3) 29 (7.5) 10 (24.4)
Ewe 31 (7.8) 23 (5.9) 1 (2.4)
Mole-dagbon 13 (3.3) 11 (2.8) 0 (0.0)
Mole-busanga 2 (0.5) 1 (0.3) 0 (0.0)
Grusi 7 (3.0) 5 (1.3) 0 (0.0)
Guan 12 (3.0) 4 (1.0) 0 (0.0)
Gruma 3 (0.8) 3 (0.8) 0 (0.0)
Other 95 (23.9) 65 (16.8) 173 (21)
Urban n (%) n = 398
183 (46.0)
n = 389
240 (61.7)
n = 41
26 (63.4)
< 0.01
Education (years) n = 253
10 (4)
n = 267
10 (5)
n = 26
10 (6)
0.51
BMI kg/m2 n = 387
24.8 (7.0)
n = 364
25.7 (7.4)
n = 39
28.1 (8.2)
0.04
Salt intake g/d n = 398
7.5 (7.4)ab
n = 384
8.6 (6.6)ac
n = 40
13.9 (11.9)bc
< 0.01
K intake, mmol/d n = 399
93.4 (97.8)ab
n = 389
49.5 (38.7)b
n = 41
38.2 (38.4)a
< 0.01
Na: K n = 399
1.4 (0.6)ab
n = 389
3.0 (1.3)ac
n = 41
5.5 (1.3)bc
< 0.01
Urinary iodine excretion, mmol/day n = 383
129.7 (116.0)a
n = 370
153.9 (164.4)
n = 40
146.9 (193.9)a
< 0.01
Systolic BP, mmHg n = 398
126 (26)
n = 385
126 (32.0)
n = 40
125 (34.0)
0.03
Diastolic BP, mmHg n = 398
77 (17.0)
n = 385
75 (17.0)
n = 40
77 (18.0)
0.25
Pulse pressure, mmHg n = 398
48 (16.6)
n = 385
51 (17.0)
n = 40
51.7 (15.0)
0.26
Mean Arterial Pressure (MAP), mmHg n = 399
93.7 (18.8)
n = 387
92.5 (21.2)
n = 41
91.7 (25.3)
0.61
Hypertension Prevalence, n (%) n = 398
170 (42.7)
n = 387
178 (46.0)
n = 40
18 (45.0)
0.65
Hypertension awareness, n (% of hypertension prevalence) n = 170
102 (60.0)
n = 178
106 (59.6)
n = 18
11 (61.1)
0.10
AHT, current use n (% of hypertension awareness) n = 102
65 (63.7)
n = 106
79 (74.8)
n = 11
7 (63.6)
0.22
Hypertension control, n (% of AHT) n = 63
33 (52.5)
n = 78
40 (51.3)
n = 7
3 (42.9)
0.89
Stroke, n (%) n = 399
11 (2.8)
n = 389
7 (1.8)
n = 41
0 (0.0)
0.45
Diabetes, n (%) n = 399
34 (8.5)
n = 389
30 (7.7)
n = 41
2 (4.9)
0.69
Tobacco use, n (%) n = 399
45 (11.3)
n = 389
34 (8.7)
n = 41
0 (0.0)
0.05
Alcohol use, n (%) n = 399
160 (40.1)
n = 389
172 (44.2)
n = 41
19 (46.3)
0.44
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Fig. 2 Slope of systolic, diastolic, pulse pressure and MAP with age in low (< 5 g/day, n = 154), medium (5–9 g/day, n = 220) and high (> 9 g/day,
n = 302) salt groups excluding those on bp medication
Table 3 Nested cohort by urinary sodium to potassium (Na:K) ratio, low, medium and high groups, WHO – SAGE Ghana Wave 3 (2019)
(Continued)
Characteristics Low Na: K (< 2)
n = 399
Medium
Na: K (2–5)
n = 389
High Na: K (> 5)
n = 41
p value
Fruits and Veg., met recommendation n (%) n = 399
212 (53.1)
n = 389
203 (52.2)
n = 41
24 (58.5)
0.74
Frequently add salt to food at the table, n (%) n = 399
52 (13)
n = 389
48 (12.3)
n = 41
6 (14.6)
0.88
Frequently add salt to cooking at home, n (%) n = 399
320 (80.0)
n = 389
311 (79.9)
n = 41
33 (80.5)
0.30
Believes that they are eating just the right amount of salt n (%) n = 397
247 (62.2)
n = 387
231 (59.7)
n = 41
24 (58.5)
0.48
Believes a high salt diet can cause a serious health problem, n (%) n = 389
304 (78.1)
n = 375
311 (82.9)
n = 40
30 (75.0)
0.18
Does something to control salt consumption, n (%) n = 389
166 (42.7)
n = 375
209 (55.7)
n = 39
15 (61.5)
< 0.01
Data are presented as median (IQR, interquartile range) unless otherwise stated. BMI, body; hypertension prevalence, BP ≥ 140/90 or previous diagnosis;
AHT, antihypertensive medication use in the last 2 weeks; BMI, body mass index; tobacco use by self-report; alcohol use by self-report; met fruits and
vegetable recommendation indicates consumed five or more servings of fruits and vegetables a day; salt behaviour responses, frequently indicates
‘always’ and ‘often’; continuous variables compared using Independent Kruskal-Wallis Test and categorical variables compared using Pearson Chi-
Square Test and Fisher’s Exact Test. a, b, c; sig at p < 0.05
Menyanu et al. BMC Nutrition            (2020) 6:54 Page 9 of 15
mandatory salt reduction policies. Surprisingly, salt intake
in the current study was higher in women than men, which
is in contrast to findings of other studies [40, 41], and war-
ranting further investigation.
Our data provides much-needed information required
to inform strategies to meet the WHO global voluntary
target for NCD prevention of 30% reduction in mean
population intake of salt, with the aim of achieving a tar-
get of less than 5 g per day by 2025 [8]. The only other
available information on 24 h urinary Na excretion in
Ghana was collected over a decade ago when salt intake
was estimated to be 6.0 g/day [42]. Over this time, the
Ghanaian food environment has changed dramatically
[43, 44] with the emergence of energy dense, nutrient
poor, processed convenience foods such as instant noo-
dles, salty snacks (eg, potato, corn, and tortilla chips),
visible fat (e.g. butter, margarine, oils, dressings and gra-
vies), ready-made baked foods (e.g. cookies, cakes, pies
and pastries), desserts such as puddings and cheesecake,
and sweetened products (e.g. sugar, syrup, ice cream,
candy, and carbonated and noncarbonated sweetened
drinks). Additionally, frequent consumption of highly
salted foods, such as fish and meat, remains part of the
traditional Ghanaian cuisine, and salt use in cooking re-
mains high [42, 45].
It is noteworthy that more than three quarters of
participants in the current study reported adding salt to
food during cooking. Poor salt use behavior is wide-
spread in the Ghanaian population; a previous study
involving 12 villages in Ghana in 2006 reported that 98%
of participants added salt to food during cooking, while
about half (52%) added salt to food at the table [21]. In
comparison to South Africans, Ghanaians reported adding
salt to food during cooking more frequently [45], presum-
ably because mass media public health campaigns to lower
salt use, such as Salt Watch in South Africa have not yet
occurred in Ghana [46]. Further, Ghana’s national salt
iodization programme, along with accompanying major
public health campaigns on iodine consumption [47–50]
may partially be responsible for an increase in discretion-
ary salt intake. However, lack of information on sources of
salt provided from discretionary and non-discretionary
Fig. 3 Slope of systolic, diastolic and pulse pressure with age in low (< 2mmol/mmol, n = 334), medium (2–5 mmol/mmol, n = 308) and high (>
5 mmol/mmol, n = 34) Na: K groups excluding those on bp medication
Menyanu et al. BMC Nutrition            (2020) 6:54 Page 10 of 15
sources, as in processed foods, prevents further hypothesis
in this regard.
Despite the current study not including a dietary
assessment component, a recent systematic review of
dietary sources of salt in LMICs identified that bread,
meat and meat products, bakery products, instant noo-
dles, salted preserved foods, milk and dairy products,
and condiments were major sources thereof [51]. In
some LMICs, bread alone may contain as much as 1.36 g
salt per 100 g bread [52]. For many African countries,
bread has become a staple food, such as in some regions
of Democratic Republic of Congo, where bread has re-
placed cassava [53]. The nutrition transition taking place
in Sub Saharan Africa and its transformation of dietary
patterns from a reliance on traditional staples to an in-
creased intake of energy dense, nutrient poor foods (and
often Na rich) foods may partly be responsible for the
observed high salt intake reported by this study. In sup-
port of this, the Ghana Demographic and Health Survey
2014 reported that more than a third (36%) of partici-
pants consumed salted dried fish [54], while in the
Ghana National Iodine Survey Report 2015, consump-
tion of bouillon cubes was frequent and widespread with
nearly half (48.8%) of the participants having consumed
this item at least 6 times a week [55].
Awareness of excessive salt intake was low in the current
study. Sixty one percent of participants believed that they
were meeting the salt recommendation guidelines, but only
22.3% actually achieved this. Estimations of dietary salt
intake using dietary recall methods usually indicates a re-
duced daily intake compared to 24 h urinary collections
[56–58]. The tendency to under-estimate salt consumption
is high as many people are unaware of the recommendation
for salt consumption, unable to determine the salt content
of everyday foods such as bread and cereals, or that of com-
posite meals [59–61]. In Ghana, there are no salt reduction
strategies in place such as: mandatory or voluntary levels of
salt permitted in processed foods; regulations for food la-
belling to indicate salt content in products, or front-of-pack
signposting for high salt warnings. In addition, the Ghan-
aian food composition tables are outdated and incomplete
in the case of Na [62], making it difficult to assess food
contributors to total salt intake. In view of this, regular
monitoring and evaluation of the food environment and
food consumption patterns are warranted.
Potassium excretion, although low (median 63.8mmol
/day, IQR 74.8, with 65% not meeting the recommended
daily intake of K), was higher than that reported by other
studies in the region [31, 39]. The K content of the food
items obtained from the 2010–2011 Ghana Food Balance
Sheet indicated that K supply per capita per day was about
9086mg/day (233mmol/day), approximately 2.6-fold lar-
ger than the WHO recommended level (> 90mmol/day)
with yams, cassava and plantains constituting the bulk of
K supply [63, 64]. However, food balance sheets represent
apparent, rather than actual food consumption, and
thereby provide an overestimation of intake.
Hypertension prevalence in the current study was high
(50 + y, 52.6%; 18-48y, 14.5%), with less than two thirds
(60%) of participants classified as hypertensives being
aware of the condition (i.e. diagnosed), of which 69.1%
were being treated with antihypertensive medication,
half of which had BP levels considered to be controlled
(< 140/90 mmHg). Surprisingly, we found no association
between urinary Na, K or N:K ratio with BP in contrasts
to findings from other comparable studies [65–67] but
in agreement with others [31, 68]. A possible reason
may be the day to day variability in salt intake, which
results in a high intra-individual variability in urinary Na
excretion. Though 24 h Na excretion is considered to be
the gold standard method for determination of popula-
tion Na intake, repeated 24 h collections over periods
provide more accurate estimating an individual’s habit-
ual salt intake [69, 70]. However, this approach is typic-
ally impractical for large population studies such as the
one reported here.
Similarly, no difference was found between the slopes
of SBP, DBP or PP with age according to three categor-
ies of salt intake, namely low (5 g/day), medium (5-9 g/
day) and high (> 9 g/day). However, high and medium
urinary Na: K had steeper slopes of BP with age as com-
pared with those in the low Na: K category. A national
survey (WHO SAGE Wave 2 South Africa) conducted in
2015 reported similar findings [31]. This association was
first explored in the INTERSALT study, the largest
multinational study on 24 h urinary excretion and BP
with 10,079 adults across 48 centres worldwide [66].
This implies that a simultaneous increase in K and a de-
crease in Na will be beneficial in reducing BP with age
and ultimately hypertension incidence [38, 66]. As such,
strategies such as taxes on high-salt products, labelling
and effective communication, voluntary salt commit-
ments by food industries and legislations for Na reduc-
tion are warranted. Similarly, to increase K intake,
nutrition promotion of K rich fruits and vegetables may
be needed, along with policies that make these foods
more accessible and affordable.
A strength of the study is the use of a large nationally
representative sample of participants aged 50+ years, in
keeping with the aim of WHO SAGE studies. This
design on the other hand, may limit generalization to
the entire population. Another potential limitation is the
recruitment strategy which resulted in more women
than men. Women are known to be more likely to vol-
unteer to participate in surveys than men [71], and this
has been observed in other 24 h urine collection studies
[31, 39]. Akan is the largest ethnic group in Ghana that
is well distributed across the entire country [54] which is
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why this group was proportionally larger than other
ethnic groups in the sample. Additionally, the cross-
sectional analysis limits the ability to evaluate the influ-
ence of dietary Na and K intake on BP over time. The
choice of urine volumes as a sole determinant of com-
pleteness of 24 h urine collections requires explanation.
Presently, there is no universally accepted standard for
determining completeness of 24 h urine collections. The
International Consortium for Quality Research on Dietary
Sodium/Salt (TRUE), recommends the use of para-
aminobenzoic acid (PABA) as being the preferred method
[72] but experiences using PABA in African communities
is limited and experiences from South Africa [73] suggest
that participants may forget or choose not to take their
PABA tablets during the urine collection period, thus ren-
dering this method impractical .
The TRUE consortium recognized a need to estab-
lish further additional measures of assessing 24 h
urinary completeness beyond PABA. A systemic re-
view found that no single exclusion criteria (24 h
urinary creatinine excretion, creatinine index < 0.7,
total urinary volume, a combination of creatinine ex-
cretion and total urine volume or self-report of miss-
ing urine) appeared more accurate in identifying
incomplete 24-h urine collections than any others
[74]. Importantly, the authors point out that the use
of a combination of methods such as creatinine ex-
cretion together with urinary volume may lead to the
unnecessary exclusion of participants with complete
urine samples. The reference values used as a cut-off
for inadequate urinary collection based on creatinine
values has largely been based on those recommended
by Stolarz-Skrzypek et al., namely urinary volume <
300 ml, or creatinine excretion < 4 mmol or > 25 mmol
for women and < 6 mmol and > 30 mmol for men [28].
The applicability of these creatinine excretion refer-
ence values across different ethnic groups has recently
been questioned [74]. While the TRUE authors con-
cluded that a creatinine index < 0.7 may best increase
the sensitivity of eliminating incomplete urine sam-
pling, they go on to promote the use of similar meth-
odologies used by the INTERSALT and INTERMAP
studies as the preferred method to determine 24 h
urinary completeness in population based studies [27,
75]. These were as follows: samples that fell outside
of the collection time of 22–26 h; participants’ indica-
tion that the collection was incomplete and that they
had spilled ‘more than a few drops’ of urine; or if
total urinary volume was < 250 ml. Given that creatin-
ine is generally variable and largely dependent on
muscle mass and protein intake [74], and the refer-
ence cut-off values in African populations have not
been widely validated, we opted to use 24 h urinary
volumes ≤300 ml as the measure for incomplete
collections. The generally low creatinine excretion
values found across the entire cohort suggest a pos-
sible low dietary protein intake, but a lack of dietary
data precludes further consideration in this regard.
Conclusions
This nationwide study of Ghanaians, using 24 h urinary
collections, reported a high intake of salt, accompanied
by a low K intake. Increasing urinary Na: K ratio was
associated with increasing BP with age. Given the high
prevalence of hypertension in the study, our findings
identify a need for population-wide strategies to reduce
dietary salt intake whilst, at the same time, increase K
intake in Ghana.
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